Free Trial

Cardlytics (CDLX) Stock Price, News & Analysis

Cardlytics logo
$0.65 0.00 (-0.23%)
Closing price 04:00 PM Eastern
Extended Trading
$0.64 -0.02 (-2.31%)
As of 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Cardlytics Stock (NASDAQ:CDLX)

Advanced

Key Stats

Today's Range
$0.63
$0.66
50-Day Range
$0.60
$1.18
52-Week Range
$0.57
$3.28
Volume
442,594 shs
Average Volume
846,541 shs
Market Capitalization
$37.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.00
Consensus Rating
Sell

Company Overview

Cardlytics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
60th Percentile Overall Score

CDLX MarketRank™: 

Cardlytics scored higher than 60% of companies evaluated by MarketBeat, and ranked 150th out of 298 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cardlytics has received a consensus rating of Sell. The company's average rating score is 1.33, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 2 sell ratings.

  • Upside Potential

    Cardlytics has a consensus price target of $1.00, representing about 53.8% upside from its current price of $0.65.

  • Amount of Analyst Coverage

    Cardlytics has only been the subject of 2 research reports in the past 90 days.

  • Read more about Cardlytics' stock forecast and price target.
  • Earnings Growth

    Earnings for Cardlytics are expected to grow in the coming year, from ($0.11) to $0.02 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cardlytics is -0.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cardlytics is -0.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Cardlytics' valuation and earnings.
  • Percentage of Shares Shorted

    14.06% of the float of Cardlytics has been sold short.
  • Short Interest Ratio / Days to Cover

    Cardlytics has a short interest ratio ("days to cover") of 7.11.
  • Change versus previous month

    Short interest in Cardlytics has recently decreased by 13.21%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Cardlytics does not currently pay a dividend.

  • Dividend Growth

    Cardlytics does not have a long track record of dividend growth.

  • News Sentiment

    Cardlytics has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.77 average news sentiment score of Business Services companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Cardlytics this week, compared to 3 articles on an average week.
  • Search Interest

    2 people have searched for CDLX on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cardlytics insiders have sold 87.06% more of their company's stock than they have bought. Specifically, they have bought $129,000.00 in company stock and sold $241,312.00 in company stock.

  • Percentage Held by Insiders

    5.90% of the stock of Cardlytics is held by insiders.

  • Percentage Held by Institutions

    68.10% of the stock of Cardlytics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Cardlytics' insider trading history.
Receive CDLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardlytics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CDLX Stock News Headlines

Elon Musk’s $1 Quadrillion AI IPO
$1 quadrillion would be enough to send a $2.8 million check to every man, woman, and child in America. That is the scale of what analysts are calling the biggest AI IPO in history.And right now, you can claim a stake before the company goes public, starting with just $500.Elon Musk is predicting this investment could climb 1,000x from here. Early access is available today.tc pixel
Cardlytics (NASDAQ:CDLX) CFO Buys $31,500.00 in Stock
5 Best Penny Stocks Under $1 According to Hedge Funds
See More Headlines

CDLX Stock Analysis - Frequently Asked Questions

Cardlytics' stock was trading at $1.15 at the start of the year. Since then, CDLX stock has decreased by 43.5% and is now trading at $0.65.

Cardlytics, Inc. (NASDAQ:CDLX) announced its quarterly earnings data on Wednesday, March, 4th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by $0.08. The company earned $56.10 million during the quarter, compared to analysts' expectations of $54.46 million. Cardlytics had a negative net margin of 46.03% and a negative trailing twelve-month return on equity of 956.56%.
Read the conference call transcript
.

Cardlytics subsidiaries include Bridg, DOSH, Cardlytics Services India Private Limited, and Cardlytics UK Limited.

Cardlytics (CDLX) raised $76 million in an initial public offering on Friday, February 9th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

Cardlytics' top institutional investors include Renaissance Technologies LLC (0.20%) and Bank of America Corp DE (0.06%). Insiders that own company stock include Clifford Sosin, Amit Gupta, Karim Saad Temsamani, David Thomas Evans, Alexis Desieno, Nicholas Hollmeyer Lynton and Andrew Christiansen.
View institutional ownership trends
.

Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardlytics investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Intel (INTC) and Rambus (RMBS).

Company Calendar

Last Earnings
3/04/2026
Today
6/03/2026
Next Earnings (Estimated)
8/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Technology Services
Sub-Industry
Computer Software
Current Symbol
NASDAQ:CDLX
CIK
1666071
Fax
N/A
Employees
500
Year Founded
2008

Price Target and Rating

High Price Target
$1.00
Low Price Target
$1.00
Potential Upside/Downside
+53.8%
Consensus Rating
Sell
Rating Score (0-4)
1.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.77)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$103.49 million
Net Margins
-46.03%
Pretax Margin
-52.00%
Return on Equity
-956.56%
Return on Assets
-34.57%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.17
Quick Ratio
2.17

Sales & Book Value

Annual Sales
$233.27 million
Price / Sales
0.16
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.12) per share
Price / Book
-5.42

Miscellaneous

Outstanding Shares
57,610,000
Free Float
54,207,000
Market Cap
$37.45 million
Optionable
Optionable
Beta
0.58

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:CDLX) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners